跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-CIPROFLOXACIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-CIPROFLOXACIN
Authorized
STANDARD
AG-CIPROFLOXACIN
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9d4716a418f67604
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
9d4716a418f67604
Drug Approval Canada Name
AG-CIPROFLOXACIN
Product Name
AG-CIPROFLOXACIN
Status
Dormant
Status Date
2022-07-26
Original Market Date
2020-01-20
Din
02476592
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.18
Atc Original
J01MA02 CIPROFLOXACIN
Atc Name
j 01 ma 02
Aig Number
0123207001
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
500 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9d4716a418f67604
Type
Standard
Back to Health Canada Approvals